Genetically defined conditions

Search documents
BioMarin Pharmaceutical(BMRN) - 2025 FY - Earnings Call Transcript
2025-09-04 13:47
BioMarin Pharmaceutical (BMRN) FY 2025 Conference September 04, 2025 08:45 AM ET Company ParticipantsMohit Bansal - MD & Co-Head of Therapeutics ResearchGreg Friberg - EVP, Chief Research & Development OfficerMohit BansalThank you very much for joining us today. My name is Mohit Bansal. I'm one of the biotech pharma analysts here at Wells Fargo. And this is my first session of the morning, and I'm very happy to have from BioMarin, Greg Fryberg with us.Greg is the EVP and Chief Research and Development Offic ...